IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $462,157 | -49.2% | 101,573 | -21.4% | 0.00% | – |
Q2 2023 | $909,568 | -3.6% | 129,200 | -16.4% | 0.00% | – |
Q1 2023 | $943,909 | -65.0% | 154,486 | -63.4% | 0.00% | -100.0% |
Q4 2022 | $2,694,088 | -82.8% | 421,610 | -74.3% | 0.00% | -66.7% |
Q3 2022 | $15,706,000 | +6.6% | 1,639,535 | +22.9% | 0.00% | 0.0% |
Q2 2022 | $14,728,000 | -92.2% | 1,334,062 | -88.2% | 0.00% | -90.6% |
Q1 2022 | $187,957,000 | +2.7% | 11,288,726 | +17.8% | 0.03% | +10.3% |
Q4 2021 | $182,959,000 | -16.6% | 9,584,082 | +7.7% | 0.03% | -21.6% |
Q3 2021 | $219,462,000 | +16.3% | 8,899,530 | +22.7% | 0.04% | +19.4% |
Q2 2021 | $188,677,000 | -17.8% | 7,251,243 | +0.0% | 0.03% | -22.5% |
Q1 2021 | $229,460,000 | -11.9% | 7,247,657 | +29.1% | 0.04% | -16.7% |
Q4 2020 | $260,394,000 | +1122.0% | 5,611,932 | +767.0% | 0.05% | +1100.0% |
Q3 2020 | $21,309,000 | +19.5% | 647,310 | -0.3% | 0.00% | 0.0% |
Q2 2020 | $17,827,000 | -66.4% | 649,432 | -63.4% | 0.00% | -71.4% |
Q1 2020 | $53,116,000 | -20.2% | 1,774,372 | -26.2% | 0.01% | 0.0% |
Q4 2019 | $66,535,000 | +218.3% | 2,403,704 | +109.3% | 0.01% | +180.0% |
Q3 2019 | $20,905,000 | +120.1% | 1,148,635 | +196.5% | 0.01% | +150.0% |
Q2 2019 | $9,498,000 | +1074.0% | 387,377 | +512.6% | 0.00% | – |
Q2 2018 | $809,000 | -33.3% | 63,237 | -11.9% | 0.00% | – |
Q1 2018 | $1,213,000 | – | 71,785 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |